CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 97 filers reported holding CYTOSORBENTS CORP in Q3 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $17,000 | -15.0% | 2,229 | +3.1% | 0.00% | – |
Q2 2020 | $20,000 | +150.0% | 2,161 | 0.0% | 0.00% | – |
Q1 2020 | $8,000 | 0.0% | 2,161 | 0.0% | 0.00% | – |
Q4 2019 | $8,000 | -20.0% | 2,161 | 0.0% | 0.00% | – |
Q3 2019 | $10,000 | -28.6% | 2,161 | 0.0% | 0.00% | – |
Q2 2019 | $14,000 | -12.5% | 2,161 | 0.0% | 0.00% | – |
Q1 2019 | $16,000 | 0.0% | 2,161 | 0.0% | 0.00% | – |
Q4 2018 | $16,000 | -83.7% | 2,161 | -75.1% | 0.00% | – |
Q2 2018 | $98,000 | -16.2% | 8,662 | -54.4% | 0.00% | -100.0% |
Q3 2017 | $117,000 | +39.3% | 19,008 | 0.0% | 0.00% | – |
Q2 2017 | $84,000 | 0.0% | 19,008 | 0.0% | 0.00% | – |
Q1 2017 | $84,000 | -17.6% | 19,008 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $102,000 | -15.7% | 19,008 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $121,000 | +42.4% | 19,008 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $85,000 | +16.4% | 19,008 | 0.0% | 0.00% | – |
Q1 2016 | $73,000 | -30.5% | 19,008 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $105,000 | -39.3% | 19,008 | -31.2% | 0.00% | 0.0% |
Q3 2015 | $173,000 | +2.4% | 27,648 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $169,000 | -53.6% | 27,648 | 0.0% | 0.00% | -66.7% |
Q1 2015 | $364,000 | +32.8% | 27,648 | 0.0% | 0.00% | +50.0% |
Q4 2014 | $274,000 | – | 27,648 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 450,000 | $846,000 | 0.90% |
Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |